Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Gebhardt

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Genome Medicine|January 24, 2013
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32Andrew D Kelly, Benjamin Haibe-Kains, Katherine A Janeway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Annals of Surgery|October 8, 2003
Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapyRobert C Shamberger, Michael P LaQuaglia, Mark C Gebhardt, et al.
Annals of Surgical Oncology|May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology GroupNajat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity AnalysisAra Nazarian, Vahid Entezari, David Zurakowski, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local controlBoKyong Kim, Yen-Lin E Chen, David G Kirsch, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Cancer|September 25, 2014
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Mark C Gebhardt, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Genome Medicine|January 24, 2013
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32Andrew D Kelly, Benjamin Haibe-Kains, Katherine A Janeway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Annals of Surgery|October 8, 2003
Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapyRobert C Shamberger, Michael P LaQuaglia, Mark C Gebhardt, et al.
Annals of Surgical Oncology|May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology GroupNajat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity AnalysisAra Nazarian, Vahid Entezari, David Zurakowski, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local controlBoKyong Kim, Yen-Lin E Chen, David G Kirsch, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Cancer|September 25, 2014
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Mark C Gebhardt, et al.
Pageof 12